News
Eli Lilly is beefing up muscle health R&D, partnering with Juvena Therapeutics in a deal that includes an upfront fee and ...
1d
Zacks.com on MSNNVO Stock up on Plans to Advance Obesity Candidate AmycretinDetailed price information for Eli Lilly and Company (LLY-N) from The Globe and Mail including charting and trades.
Variants of obesity-related genes influence how much weight patients lose on specific weight loss drugs like liraglutide, two studies report.
Ozempic is FDA-approved for treating type 2 diabetes – but could it also help with other conditions like PCOS Read on to find out what an expert says ...
5d
Vietnam Investment Review on MSNAscletis presents new data on ASC30 and ASC47 at ADA 2025Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that poster presentations on preliminary studies of its oral small molecule GLP-1 Receptor (GLP-1R) agonist ASC30 and adipose-targeted, ...
Other factors that influence the impact include how much people need to eat to full feel. Researchers say they have a new ...
WEIGHT loss jabs could prevent a medication taken by millions of women from working – and increase patients’ risk of cancer. The British Menopause Society said the jabs could cause ...
Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for the ...
In what Guggenheim Partners called one of Metsera’s “critical program milestones” this year, its ultra-long-acting amylin ...
Tribune News Service on MSN1d
On Nutrition: Don’t miss the fine print on weight-loss drugsI hear a lot of talk around our small town when someone becomes noticeably thinner. “He sure has lost a lot of weight.” “Did ...
WEIGHT loss jabs could one day be dished out like statins, England’s top doctor says. Professor Sir Stephen Powis, medical ...
Losing weight and sustaining a healthy weight are notoriously difficult. If you’re struggling to reach your weight goals, you ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results